You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunooncology treatment

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Worldwide (PDR001, Cisplatin, Gemcitabine)

Terminated
  • Non-small Cell Lung Cancer
  • Fayetteville, Arkansas
  • +22 more
Aug 11, 2022

Advanced Solid Tumors Trial in Canada, Singapore, United States (BAY3375968, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumors
  • Chicago, Illinois
  • +4 more
Sep 9, 2022

Extensive Stage Small Cell Lung Cancer Trial (Tarlatamab, Carboplatin, Etoposide)

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Los Angeles, California
  • +37 more
Feb 1, 2023

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head Cancer Trial in United States (IK-175 + nivolumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +5 more
  • IK-175 + nivolumab
  • Chicago, Illinois
  • +3 more
Jul 26, 2022

Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in Worldwide (acapatamab, Pembrolizumab, Etanercept)

Active, not recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Prostate Cancer
  • Campbell, California
  • +29 more
Dec 6, 2022

Solid Tumors Trial in Worldwide (Entrectinib, Alectinib, Atezolizumab)

Recruiting
  • Solid Tumors
  • Daphne, Alabama
  • +156 more
Jan 13, 2023

Prostate Cancer Trial in Worldwide (AMG 509, Abiraterone, Enzalutamide)

Recruiting
  • Prostate Cancer
  • AMG 509
  • +2 more
  • Duarte, California
  • +18 more
Mar 17, 2022

Genomic Alteration in Luminal A or Luminal B Subtypes

Active, not recruiting
  • Breast Cancer
    • Athens, Greece
      George Fountzilas
    Mar 15, 2022